tiprankstipranks
pc:gilga

Gilgamesh Pharma

Therapeutics
A clinical-stage neuroscience company developing breakthrough therapies for psychiatric and neurological disorders, with a focus on next-generation neuropsychiatric treatments. Formed as a spinout following the 2025 acquisition by AbbVie, the company inherits clinical and preclinical programs and continues development of neuroplastogen-related assets and collaborations with biopharma partners.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$60M
Total Amount Raised$60M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$60M
Latest Funding Amount$60M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 24, 2026
Series A
$60.00M
―

Related News and Analysis

Gilgamesh Pharma Raises $60 Million Series A to Advance Post-Acquisition Neuropsychiatric Pipeline

Gilgamesh Pharma Raises $60 Million Series A to Advance Post-Acquisition Neuropsychiatric Pipeline

New updates have been reported about Gilgamesh Pharma. Gilgamesh Pharma, a clinical-stage neuroscience company formed after AbbVie acquired...
17d ago
GILGA
KuCoin Launches Elite Trader Program to Deepen Social Trading and Monetization Options

KuCoin Launches Elite Trader Program to Deepen Social Trading and Monetization Options

New updates have been reported about KuCoin. KuCoin has introduced its Elite Trader Premier Program, positioning the exchange...
2d ago
KUCOI
MIND Research Links Data Trust to AI Performance and Risk Management for CISOs

MIND Research Links Data Trust to AI Performance and Risk Management for CISOs

New updates have been reported about MIND. MIND has released new research, produced with the CISO Executive Network,...
2d ago
MINDX
X-Energy, Dow Advance Advanced Nuclear Demonstration for Texas Gulf Coast Industrial Site

X-Energy, Dow Advance Advanced Nuclear Demonstration for Texas Gulf Coast Industrial Site

According to a recent LinkedIn post from X-Energy Reactor Company LLC, the company is working with Dow to...
2d ago
XENER
Antimony Resources Corp Strengthens U.S. Exploration and JORC Compliance Capabilities

Antimony Resources Corp Strengthens U.S. Exploration and JORC Compliance Capabilities

According to a recent LinkedIn post from Antimony Resources Corp, the company has appointed geoscientist David Groombridge as...
2d ago
ANT2F
Mast Reforestation Highlights Biomass Burial Strategy at SF Climate Week Event

Mast Reforestation Highlights Biomass Burial Strategy at SF Climate Week Event

According to a recent LinkedIn post from Mast Reforestation, the company is co-hosting and participating in the Stabilize...
2d ago
MASTR
Carbon Highlights Additive Manufacturing Role in Performance Footwear Collaboration

Carbon Highlights Additive Manufacturing Role in Performance Footwear Collaboration

According to a recent LinkedIn post from Carbon, the company is emphasizing the role of its Digital Light...
2d ago
CARBN
Circuit Highlights People Operations as Key to Scaling Ride Service

Circuit Highlights People Operations as Key to Scaling Ride Service

According to a recent LinkedIn post from Circuit, the company is emphasizing the importance of its people operations...
2d ago
CIRCU
Carbon Showcases Healthcare-Focused 3D Printing Capabilities at RAPID + TCT

Carbon Showcases Healthcare-Focused 3D Printing Capabilities at RAPID + TCT

According to a recent LinkedIn post from Carbon, the company plans a visible presence at the RAPID +...
2d ago
CARBN
AdvantageClubai Backs SoleCX 2026 as Major Sponsor to Deepen CX Community Ties

AdvantageClubai Backs SoleCX 2026 as Major Sponsor to Deepen CX Community Ties

According to a recent LinkedIn post from AdvantageClubai, the company is highlighted as a Major Sponsor of SoleCX...
2d ago
ADVAN